Why are mRNA vaccines so successful in preventing the serious form of Covid-19 but not so great at protecting against breakthrough infections? Two professors of pathology, microbiology and immunology weigh in.
With yet another Covid-19 booster available for vulnerable populations in the U.S., many people find themselves wondering what the end game will be.
However, it has become increasingly clear that the second booster does not provide long-lasting protection against breakthrough infections. As a result, it will be necessary to retool the existing vaccines to increase the duration of protection in order to help bring the pandemic to an end. Understanding how our immune system works during the mild versus severe forms of Covid-19 is also important to the process of developing more targeted vaccines.
Why booster shots? The B cells and T cells are unique in that after they mount an initial immune response, they get converted into memory cells. Unlike antibodies, memory cells can stay in a person’s body for several decades and can mount a rapid response when they encounter the same infectious agent. It is because of such memory cells that some vaccines against diseases such as smallpox provide protection for decades.
That diminished protection even after the third dose is what led the CDC to endorse the fourth shot of Covid-19 vaccine – called the second booster – for people who are immunocompromised and those aged 50 and older.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Sinopharm to start clinical trials of Omicron specific Covid-19 vaccinesAs China struggles to contain the spread of Covid-19, it's scientists race against time to upgrade existing vaccines.
Read more »
Why we can’t ‘boost’ our way out of the COVID-19 pandemic for the long termWith yet another COVID-19 booster available for vulnerable populations in the U.S., many people find themselves wondering what the end game will be.
Read more »
Make access to COVID-19 booster shots 'ultraconvenient,' experts sayEasier access to COVID\u002D19 vaccine boosters could be a way of addressing the plateauing rates of Canadians getting the shot, public health and immunology…
Read more »
FDA Authorizes First COVID-19 Breath TestThe Food and Drug Administration on Thursday authorized the first COVID-19 test that uses breath samples.
Read more »
COVID-19: Sask. hospitalizations rise to near record levels“You can’t really call it a sixth wave, because we didn’t really come down from the fifth wave yet.\u0022
Read more »
Health Canada greenlights AstraZeneca COVID-19 drug to prevent infectionHealth Canada has approved AstraZeneca’s antibody combination to prevent symptomatic COVID\u002D19 infection in immunocompromised people.
Read more »